Vigonvita Life Sciences Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Market Capitalization	9,687	13,718	-	-
Enterprise Value	9,819	14,171	-	-
Last Close Price	57.80	81.85	-	-
PS Ratio	85.26	120.74	-	-
PB Ratio	19.98	28.29	-	-
P/TBV Ratio	23.00	32.57	-	-
EV/Sales Ratio	86.42	124.73	-	-
Debt / Equity Ratio	1.48	1.48	3.05	1.71
Debt / EBITDA Ratio	-	-	-	13.34
Net Debt / Equity Ratio	0.30	0.30	2.18	1.20
Net Debt / EBITDA Ratio	-0.41	-0.41	-1.67	15.93
Net Debt / FCF Ratio	-0.50	-0.50	-1.64	-4.01
Asset Turnover	0.10	0.10	0.02	-
Inventory Turnover	2.60	2.60	1.11	-
Quick Ratio	1.05	1.05	0.46	0.56
Current Ratio	1.07	1.07	0.50	0.58
Return on Equity (ROE)	-123.98%	-123.98%	-132.51%	-
Return on Assets (ROA)	-20.73%	-20.73%	-18.15%	-
Return on Capital Employed (ROCE)	-43.70%	-43.70%	-50.40%	1.90%
Earnings Yield	-4.09%	-2.89%	-	-
FCF Yield	-2.95%	-2.08%	-	-
Buyback Yield / Dilution	-	-4.87%	-0.69%	-